The Indian Practitioner

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Ayurvedic Dravyaguna (Pharmacological) Correlates with Biological Plausibility for Antidiabetic activity of Eujenia jambolana Linn


Affiliations
1 KHS-MRC, Mumbai and Ph D Scholar. The Centre for Ayurveda Biology and Holistic Nutrition, The University of Trans-disciplinary Health Sciences and Technology TDU, Bengaluru, India
2 Div of Endocrinology and Metabolic disorder, KHS-MRC, Mumbai, India
3 The Centre for Ayurveda Biology and Holistic Nutrition, The University of Trans-disciplinary Health Sciences and Technology, TDU Bengaluru, India
4 Clinical Research and Integrative Medicine, KHS-MRC, Mumbai, India
5 KHS-MRC, Mumbai and Emeritus Professor, The University of Trans-disciplinary Health Sciences and Technology, India
     

   Subscribe/Renew Journal


Eujenia jambolana Linn (Jambu / Black plum; EjL) was found to be a frequently used medicinal plant in our earlier study of Marketed Ayurvedic Antidiabetic Formulations. Ayurvedic dravyaguna rationale and Biological Plausibility (BP) of EjL for anti-diabetic activity are currently reviewed in view of developing a new drug candidate for type 2 diabetes mellitus using Reverse Pharmacology. Classical and emerging Ayurvedic literature as well as modern pharmacological literature of EjL were reviewed here for Ayurvedic properties and biological plausibility foranti-diabetic potentials.

Keywords

Indian Medicinal Plants, Dravyaguna Rationale, Biological Plausibility, Diabetes, Ayurvedic Pharmacoepidemiology, Jambu, Eugenia jambolana.
Subscription Login to verify subscription
User
Notifications
Font Size



  • Ayurvedic Dravyaguna (Pharmacological) Correlates with Biological Plausibility for Antidiabetic activity of Eujenia jambolana Linn

Abstract Views: 392  |  PDF Views: 0

Authors

N. S. Nabar
KHS-MRC, Mumbai and Ph D Scholar. The Centre for Ayurveda Biology and Holistic Nutrition, The University of Trans-disciplinary Health Sciences and Technology TDU, Bengaluru, India
R. A. Vaidya
Div of Endocrinology and Metabolic disorder, KHS-MRC, Mumbai, India
C. N. Vishnuprasad
The Centre for Ayurveda Biology and Holistic Nutrition, The University of Trans-disciplinary Health Sciences and Technology, TDU Bengaluru, India
A. A. Raut
Clinical Research and Integrative Medicine, KHS-MRC, Mumbai, India
A. D. B. Vaidya
KHS-MRC, Mumbai and Emeritus Professor, The University of Trans-disciplinary Health Sciences and Technology, India

Abstract


Eujenia jambolana Linn (Jambu / Black plum; EjL) was found to be a frequently used medicinal plant in our earlier study of Marketed Ayurvedic Antidiabetic Formulations. Ayurvedic dravyaguna rationale and Biological Plausibility (BP) of EjL for anti-diabetic activity are currently reviewed in view of developing a new drug candidate for type 2 diabetes mellitus using Reverse Pharmacology. Classical and emerging Ayurvedic literature as well as modern pharmacological literature of EjL were reviewed here for Ayurvedic properties and biological plausibility foranti-diabetic potentials.

Keywords


Indian Medicinal Plants, Dravyaguna Rationale, Biological Plausibility, Diabetes, Ayurvedic Pharmacoepidemiology, Jambu, Eugenia jambolana.

References